References
- Marshall B J, McGechie D B, Rogers P A, Glancy R G. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust 1985; 142: 439–444
- Graham D Y. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96: 615–625, Suppl
- Marshall B J, Warren J R, Blincow E D. Prospective double blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–1441
- Graham D Y. Campylobacter pylori & peptic ulcer disease. Gastroenterology 1989; 96(Suppl)615–625
- Wyatt J I. Epidemiology of gastric metaplasia. Helicobacter pylori 1990, H Menge, M Gregor, G NJ Tytgat, et al. Springer-Verlag, Berlin 1991; 132–138
- Wyatt J I, Rathbone B J, Sobala G M. Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol 1990; 43: 981–986
- Rauws E AJ, Tytgat G NJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233–1235
- Rauws E AJ, Tytgat G NJ. Campylobacter pylori. Thesis, Academic Medical Centre, Amsterdam 1989; 133–134
- Sipponen P. Chronic gastritis: epidemiology and relationship to peptic ulcer diseases. Helicobacter pylori 1990, H Menge, M Gregor, G NJ Tytgat, et al. Springer-Verlag, Berlin 1991
- Graham D Y, Klein P D, Opedun A R, Boutton T W. Effect of age on the frequency of active Campylobacter pylori infection diagnosed by the (13C) urea breath test in normal subjects and patients with peptic ulcer disease. J Infect Dis 1988; 157: 777–780
- Newall D G, Rathbone B J. The serodiagnosis of Campylobacter pylori infection—a review. Sero Diagn Immunother 1989; 3: 1–6
- Megraud F, Brassens-Rabbe M P, Denis F. Sero-epidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol 1989; 27: 1870–1873
- Gubbins G P, Schubert T T, Attanasio F. Gold and the sero-prevalence of Helicobacter pylori in rheumatoid arthritis patients. Gastroenterology 1991; 100: A76
- Mooney C, Munster D J, Bagshaw P F, Allardyce R A. Helicobacter pylori acid resistance. Lancet 1990; 335: 1232
- Veldhuyzen Van Zanten S JO, Goldie J, Hunt R H. Inhibition of Helicobacter pylori by acetohydroxamic acid [letter]. Lancet 1990; 336: 1584
- Munster D J, Allardyce R A, Bagshaw P F. Inhibition of Helicobacter pylori by acetohydroxamic acid [letter reply]. Lancet 1990; 336: 1584–1585
- Sobala G M, Schorah C J, Sanderson M. Ascorbic acid in human stomach. Gastroenterology 1989; 97: 357–363
- Chiba N, Rao B V, Rademaker J W, Hunt R H. Meta-analysis of Helicobacter pylori eradication trials. Gastroenterology 1991; 100: A43
- Glupczynski Y, Burette A. Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am J Gastroenterol 1990; 85: 1545–1551
- Glupczynski Y, Burette A, De Koster A. Metronidazole resistance in Helicobacter pylori. Lancet 1990; 335: 976–977
- Axon A TR. Helicobacter pylori therapy: effect on peptic ulcer disease [World Congress 1990 Working Party Report]. J Gastrohepatol 1991; 2: 131–137
- Logan R PH, Gummett P A, Misiewicz J J. A one week eradication regime for Helicobacter pylori. Gut 1991; 32: A571